GI Flashcards
(432 cards)
.
GI
Oral naloxegol is a peripherally acting μ-opioid receptor antagonist that is FDA-approved for the treatment of opioid-induced constipation in adults with chronic noncancer pain.
GI
he patient has hepatitis B virus (HBV) infection in the immune-tolerant phase, which can be determined by the likely vertical transmission and the patient’s young age, positive hepatitis B e antigen (HBeAg), high viral load, and normal aminotransferase levels.
Patients with hepatitis B infection in the immune-tolerant phase require serial monitoring of aminotransferase levels.
Patients with HBV infection in the immune-active, HBeAg-positive and reactivation, HBeAg-negative phases require treatment if the alanine aminotransferase level is elevated.
GI
Patients with HBV infection are at increased risk for hepatocellular carcinoma, even in the absence of cirrhosis. Patients from Southeast Asia should undergo hepatocellular carcinoma surveillance with ultrasonography starting at age 40 years for men and at age 50 years for women, and patients from sub-Saharan Africa should begin at age 20 years.
GI
Aspirin for secondary prophylaxis in patients with established cardiovascular disease should be continued after colonoscopy with polypectomy.
GI
Nonalcoholic fatty liver disease is the most common cause of abnormal liver test results in the United States.
The finding of a hyperechoic liver on ultrasonography is also consistent with NAFLD.
GI
The diagnosis of primary biliary cholangitis (PBC) is generally made on the basis of a cholestatic liver enzyme profile in the setting of a positive antimitochondrial antibody test
Autoimmune hepatitis is typically accompanied by higher autoantibody titers positive anti–smooth muscle antibody test
GI
Pseudoachalasia is caused by a tumor at the gastroesophageal junction infiltrating the myenteric plexus causing esophageal motor abnormalities; symptoms, barium-imaging and manometric findings, and endoscopic appearance are similar to achalasia.
Typical achalasia has an insidious onset and long duration of symptoms, often measured in years, before patients seek medical attention.
GI
A low-FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, And Polyols) diet can reduce abdominal pain and bloating and improve stool consistency, frequency, and urgency in patients with diarrhea-predominant irritable bowel syndrome.
Linaclotide is a peripherally acting guanylate cyclase-C activator approved by the FDA for the treatment of IBS-C
GI
Patients with dysphagia associated with regurgitation of undigested food should be evaluated with a barium esophagram for the presence of a Zenker diverticulum.
Treatment is reserved for symptomatic patients and endoscopic diverticulectomy is favored where surgical expertise is available.
GI
Esophageal manometry is used when there is concern for a motility disorder, such as achalasia. Patients with motility disorders commonly report dysphagia to liquids or both solids and liquids; this patient’s dysphagia to solid food does not suggest a motility disorder.
GI
Hepatopulmonary syndrome is a complication of cirrhosis caused by dilation of the pulmonary vasculature in the setting of advanced liver disease and portal hypertension. A high alveolar-arterial oxygen gradient results from functional shunting. Patients with hepatopulmonary syndrome usually have a preexisting diagnosis of liver disease and present with shortness of breath
The diagnosis of hepatopulmonary syndrome is made by demonstrating an arterial oxygen tension less than 80 mm Hg (10.7 kPa) breathing ambient air, or an alveolar-arterial gradient of 15 mm Hg (2 kPa) or greater, along with evidence of intrapulmonary shunting on echocardiography with agitated saline or macroaggregated albumin study.
GI
Cholecystectomy is the definitive treatment for acalculous cholecystitis in stable patients. However, this patient is now hemodynamically unstable and, therefore, requires a temporizing cholecystostomy tube to allow time for her to stabilize and for gallbladder inflammation to improve before cholecystectomy.
A hepatobiliary iminodiacetic acid scan may be used when ultrasonography is equivocal, and it would show nonopacification of the gallbladder in cases of cholecystitis.
GI
In patients requiring NSAIDs, an evidence-based treatment strategy to prevent recurrent NSAID-induced peptic ulcers is the use of a cyclooxygenase-2 selective NSAID plus a proton pump inhibitor.
GI
Patients with small (<10 mm) hyperplastic polyps on baseline colonoscopic examination should undergo surveillance colonoscopy in 10 years.
Sessile serrated polyps (also known as sessile serrated adenomas) and traditional serrated adenomas are both neoplastic and are precursors to colorectal cancer; they should be completely excised.
guidelines recommend managing large (>10 mm) hyperplastic polyps as if they are sessile serrated polyps.
GI
A 3-year surveillance interval is recommended for patients who have three or more adenomas (or sessile serrated polyps) found on baseline colonoscopy, one adenoma larger than 10 mm in size, or an adenoma with any degree of villous or high-grade dysplasia.
A surveillance interval of 5 years is recommended for patients with two or fewer adenomas (or sessile serrated polyps) found on baseline colonoscopy and for patients with a first-degree relative with colon cancer diagnosed at an age younger than 60 years.
GI
Patients who have cholangitis with evidence of biliary obstruction should be treated with antibiotic therapy and biliary decompression with endoscopic retrograde cholangiopancreatography.
In patients with evidence of biliary obstruction (as seen in this patient’s findings on ultrasonography) and more than mild disease, biliary decompression with ERCP is an essential component of therapy
Obstruction is typically indicated by a dilated bile duct and persistently elevated liver enzyme levels.
GI
Esophageal stricture in patients with eosinophilic esophagitis requires treatment with endoscopic dilation when symptoms do not respond to medical therapy.
Endoscopy with dilation is the most appropriate treatment for this patient, who has eosinophilic esophagitis, refractory symptoms of dysphagia despite fluticasone therapy, and the finding of an esophageal stricture on endoscopy
GI
Microscopic colitis is a cause of nonbloody, watery diarrhea in older adults and is diagnosed by colonoscopy with random biopsies from multiple colonic segments
Microscopic colitis is more common in older persons and does not cause endoscopically visible inflammation..
Microscopic colitis is associated with other autoimmune diseases such as diabetes mellitus and psoriasis
GI
Small intestinal bacterial overgrowth (SIBO) causes diarrhea, often with bloating, flatulence, and weight loss. Several conditions can predispose patients to SIBO due to effects on stomach acid, intestinal transit, or disruption of normal antibacterial defense mechanisms. Gastric bypass surgery is an increasingly common cause of SIBO. The absence of malabsorption symptoms and weight loss make this diagnosis unlikely.
GI
Almost all patients (>90%) with autoimmune pancreatitis enter clinical remission in response to glucocorticoids.
Based on his typical symptom of painless jaundice and the characteristic “sausage-shaped” pancreas on imaging, the patient has type 1 autoimmune pancreatitis, a frequent manifestation of IgG4 disease
Endoscopic retrograde cholangiopancreatography with bile-duct stenting is usually not required in patients with autoimmune pancreatitis because most patients’ symptoms respond quickly to oral prednisone
GI
The fetus should be delivered immediately upon recognition of acute fatty liver of pregnancy.
Women with acute fatty liver of pregnancy typically present with a 1- to 2-week history of nausea and vomiting, right-upper-quadrant or epigastric pain, headache, jaundice, anorexia, and/or polyuria and polydipsia.
GI
The finding of a gallbladder polyp larger than 1 cm in size, or a polyp of any size associated with gallstones, is an indication for cholecystectomy even if the patient is asymptomatic.
Cholecystectomy is indicated for this patient with a gallbladder polyp and gallstones because of the increased risk for gallbladder cancer when the two conditions coexist.
In a patient with an 8-mm gallbladder polyp in the absence of gallstones or primary sclerosing cholangitis, repeat ultrasonography in 6 months would be indicated.
GI
After eradication therapy for Helicobacter pylori infection, eradication should be confirmed using the urea breath test or fecal antigen test.
Testing to confirm eradication should be pursued in all cases of identified and treated Helicobacter pylori infection because of the established risks for peptic ulcer disease and gastric malignancy in patients with chronic H. pylori infection
Unless upper endoscopy is indicated for other reasons, noninvasive testing modalities (the urea breath test or the fecal antigen test) are more appropriate for confirmation of eradication or assessment for reinfection.
GI
Same-admission cholecystectomy reduces rates of gallstone-related complications compared with cholecystectomy after hospital discharge for patients with mild gallstone pancreatitis.